Peripheral neuropathy associated with high-dose ara-C therapy
- 15 August 1986
- Vol. 58 (4) , 852-854
- https://doi.org/10.1002/1097-0142(19860815)58:4<852::aid-cncr2820580408>3.0.co;2-i
Abstract
Central nervous system toxicity associated with high-dose cytosine arabinoside (Ara-C) therapy (HD Ara-C) is well known. The authors report the case of a severe isolated peripheral polyneuropathy due to HD Ara-C. Electrophysiologic changes and histologic observations were consistent with axonal degeneration and scattered destruction of myelin sheaths. This observation emphasizes the need for careful complete neurologic evaluation for patients receiving HD Ara-C treatment.This publication has 12 references indexed in Scilit:
- Ocular toxicity from high-dose cytosine arabinosideCancer, 1983
- Acute cerebellar dysfunction with high-dose ARA-C therapyCancer, 1983
- Central nervous system toxicity of high-dose systemic cytosine arabinosideCancer, 1981
- Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols.A clinical-pathologic study of 33 patientsCancer, 1978
- Letter: neuropathy due to cytosine arabinoside.BMJ, 1974
- Febrile Response to CytarabineJAMA, 1974
- The neuromyopathy of vincristine in manJournal of the Neurological Sciences, 1970
- Vincristine‐induced neuropathyNeurology, 1969